Trem2/Tyrobp Signaling Protects Against Aortic Dissection and Rupture by Inhibiting Macrophage Activation in Mice
- PMID: 39508103
- DOI: 10.1161/ATVBAHA.124.321429
Trem2/Tyrobp Signaling Protects Against Aortic Dissection and Rupture by Inhibiting Macrophage Activation in Mice
Abstract
Background: The development of aortic dissection (AD) is closely associated with inflammation. The Trem2 (triggering receptor expressed on myeloid cells 2)/Tyrobp (TYRO protein tyrosine kinase-binding protein) signaling pathway critically regulates innate immunity and has emerged as an important target in cardiovascular diseases; however, its role in AD remains unclear.
Methods: Transcriptome data from human and mouse ADs were used to perform differentially expressed gene-based protein-protein interaction network analyses. Tyrobp knockout (Tyrobp-/-), myeloid cell-specific Tyrobp-/- (Tyrobpfl/fl Lyz2cre), and Trem2 knockout (Trem2-/-) mice were given β-aminopropionitrile monofumarate in drinking water to induce AD. To dissect the role of macrophages in Tyrobp deficiency-mediated AD progression, macrophages were depleted using clodronate liposomes. Bulk and single-cell RNA sequencing, immunofluorescence staining, and quantitative real-time polymerase chain reaction were performed to assess inflammation and the underlying mechanisms of Tyrobp in AD.
Results: Network analysis identified Tyrobp as a hub gene of AD, with elevated levels observed in both human and mouse ADs. Global deletion and myeloid cell-specific deficiency of Tyrobp in mice significantly increased AD incidence and exacerbated extracellular matrix degradation and macrophage infiltration within the aortic wall. Macrophage depletion mitigated the adverse effects of Tyrobp deficiency on AD progression. Additionally, Tyrobp deficiency enhanced TLR (Toll-like receptor)-4 signaling and macrophage activation, which were abrogated by TLR4 inhibitors. Furthermore, deletion of the Tyrobp-associated receptor Trem2 significantly aggravated mouse AD development, whereas Trem2 agonist treatment conferred protection against AD.
Conclusions: Our findings suggest a novel role for the Trem2/Tyrobp axis in AD development in mice. Enhancement of Trem2/Tyrobp signaling may represent a promising strategy for the prevention and treatment of AD. Future studies to clarify the role of Trem2/Tyrobp in human AD are warranted.
Keywords: aortic dissection; incidence; inflammation; liposomes; macrophages.
Conflict of interest statement
None.
Similar articles
-
Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models.Genome Med. 2018 Mar 29;10(1):26. doi: 10.1186/s13073-018-0530-9. Genome Med. 2018. PMID: 29598827 Free PMC article.
-
March2 Alleviates Aortic Aneurysm/Dissection by Regulating PKM2 Polymerization.Circ Res. 2025 Apr 11;136(8):e73-e93. doi: 10.1161/CIRCRESAHA.124.325049. Epub 2025 Mar 13. Circ Res. 2025. PMID: 40079144
-
A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.J Biol Chem. 2017 Jun 23;292(25):10651-10663. doi: 10.1074/jbc.M116.759159. Epub 2017 May 10. J Biol Chem. 2017. PMID: 28490631 Free PMC article.
-
Microglial TYROBP/DAP12 in Alzheimer's disease: Transduction of physiological and pathological signals across TREM2.Mol Neurodegener. 2022 Aug 24;17(1):55. doi: 10.1186/s13024-022-00552-w. Mol Neurodegener. 2022. PMID: 36002854 Free PMC article. Review.
-
TYROBP in Alzheimer's disease.Mol Neurobiol. 2015 Apr;51(2):820-6. doi: 10.1007/s12035-014-8811-9. Epub 2014 Jul 23. Mol Neurobiol. 2015. PMID: 25052481 Review.
Cited by
-
Cystatin F-a key player in central nervous system disease.J Neuroinflammation. 2025 Aug 14;22(1):203. doi: 10.1186/s12974-025-03526-z. J Neuroinflammation. 2025. PMID: 40813983 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources